Efficacy of Amantadine Treatment in COVID-19 Patients

Clinical trial NCT04952519 · TERMINATED

Trial details

NCT number: NCT04952519
Sponsor: Noblewell
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Patients With Moderate or Severe COVID-19

Start date: 2021-03-30
Primary completion: 2022-03-10
Enrollment: 193

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.